HLB Co., Ltd.

A028300

KR7028300002

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
108,500 ^KRW	+1.69%		+16.42%	+114.00%

Apr. 01	HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	CI
Mar. 22	HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%	MT

HLB Co., Ltd. announced that it has received KRW 20 billion in funding from Oasis Management Company Ltd., History Investment Co., Ltd.

June 13, 2019

On June 14, 2019, HLB Co., Ltd. (KOSDAQ:A028300) closed the transaction.

Latest news about HLB Co., Ltd.

HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	Mar. 31	CI
HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%	Mar. 22	MT
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 29.99999658 billion in funding from HLB Co., Ltd. and other investors	Mar. 21	CI
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
HLB Co., Ltd. announced that it has received KRW 60 billion in funding from a group of investors	Mar. 07	CI
HLB Co., Ltd. announced that it expects to receive KRW 60 billion in funding from a group of investors	Mar. 03	CI
Bank of Canada Holds Rates Steady; ECB Expected -2-	Jan. 25	DJ
South Korean Shares Marginally Decline for Second Day on Profit-Booking	Dec. 22	MT
HLB Shareholders Endorse Transition to Main Bourse from KOSDAQ	Dec. 22	MT
BPH Energy Appoints HLB Mann Judd as Auditor; Shares Plunge 10%	Nov. 21	MT
Century Sunshine Group’s Auditor Resigns; Successor Named	Nov. 17	MT
Rare Earth Magnesium’s Auditor Steps Down; Successor Appointed	Nov. 17	MT
Jinhai International Gets New Auditor	Nov. 14	MT
HLB Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
HLB, Hong Leong Islamic Bank, Cagamas Conclude MYR300 Million Green Assests Deal	23-10-04	MT
Spenda Halts Trade Pending Court Nod for Auditor Appointment	23-09-04	MT
5E Resources Appoints New Auditors	23-09-01	MT
Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.	23-08-10	CI
Elevar Therapeutics, Inc. announced that it expects to receive KRW 58.174676146 billion in funding from HLB Co., Ltd.	23-08-08	CI
Hong Leong Bank Digital Banking Platforms Grow 22% as of May	23-07-07	MT
Panagene Inc. announced that it expects to receive KRW 56.599994061 billion in funding from a group of investors	23-06-20	CI
Panagene Inc. announced that it expects to receive KRW 46.068324061 billion in funding from HLB Co., Ltd., HLB Investment Co., Ltd., HLB bioStep Co.,Ltd., HLB innoVation Co.,Ltd., HLB Therapeutics Co.,Ltd.	23-06-20	CI
HLB Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Ban Loong Appoints New Auditor	23-05-01	MT
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI

HLB Inc is a Korea-based company mainly engaged in the manufacture and sale of lifeboats and pipes. The Company operates its business through two segments. The Composite Material segment is mainly engaged in the construction and repair of lifeboats, the manufacture and installation of pipes. The Biomedical Device Business segment is mainly engaged in the development of biopharmaceuticals, the manufacture and sale of medical devices.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-13 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
HLB CO., LTD.	+114.00%	10.3B
ABBOTT LABORATORIES	-2.89%	185B
MEDTRONIC PLC	-2.43%	107B
BECTON, DICKINSON AND COMPANY	-4.10%	67.55B
DEXCOM, INC.	+11.10%	54.6B
CENCORA, INC.	+15.86%	47.42B
HOYA CORPORATION	+4.03%	42.24B
WEST PHARMACEUTICAL SERVICES, INC.	+9.55%	28.24B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.85%	26.42B
TERUMO CORPORATION	+12.53%	25.66B